Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
PET, CT and MRI volumes are accelerating. Learn what uneven imaging growth means for valuation and long-term planning.
Growth strategies in behavioral health are shifting. Learn how leaders can respond to industry headwinds and optimize performance effectively.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Weaver’s pre-transaction due diligence services helped a multinational real estate corporation move forward with confidence on a global acquisition.
Costs are climbing across health care supply chains. Learn which areas face the most pressure and how to plan with confidence.
Weaver helps a health system evaluate its revenue quality, estimate collections and gain clarity on complex streams.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
Our Health Care Valuation Insights Hub is your go-to resource for knowledge and strategies to stay ahead in an evolving industry.
Weaver’s transaction advisory team highlights a recent success guiding a client through a contentious net working capital and earn-out dispute.
FY 2026 ACA enrollment growth may impact health care valuations. Learn how the shift may shape provider revenue and risk.
Weaver supported an aviation management firm with sell-side financial and tax assistance, saving the client over $1 million in post-close adjustments.
1 2 3 4 12